MyFinsight
Home
Blog
About
Back
Cash Flow
Marker Therapeutics, Inc. (MRKR)
Marker Therapeutics, Inc. (MRKR)
source: myfinsight.com
Net decrease in
cash, cash...
-$3,716,323
(49.63%↑ Y/Y)
Stock-based compensation
$195,735
(-50.21%↓ Y/Y)
Net cash used in
operating activities
-$3,716,323
(49.63%↑ Y/Y)
Canceled cashflow
$195,735
Net loss
-$1,826,229
(78.42%↑ Y/Y)
Accounts payable and
accrued expenses
-$889,768
(-273.13%↓ Y/Y)
Prepaid expenses and
deposits
$625,623
(-21.29%↓ Y/Y)
Other receivables
$242,177
(136.02%↑ Y/Y)
Related party payable
-$196,434
(81.36%↑ Y/Y)
Deferred grant income
-$131,827
Back